Ubiquitin Ligase Activities of WWP1 Germline Variants K740N and N745S

被引:9
|
作者
Jiang, Hanjie [1 ,2 ]
Dempsey, Daniel R. [1 ]
Cole, Philip A. [1 ,2 ]
机构
[1] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Div Genet, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1021/acs.biochem.0c00869
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
WWP1 is an E3 ubiquitin ligase that has been reported to target the tumor suppressor lipid phosphatase PTEN. K740N and N745S are recently identified germline variants of WWP1 that have been linked to PTEN-associated cancers [Lee, Y. R., et al. (2020) N. Engl. J. Med.]. These WWP1 variants have been suggested to release WWP1 from its native autoinhibited state, thereby promoting enhanced PTEN ubiquitination as a mechanism for driving cancer. Using purified proteins and in vitro enzymatic assays, we investigate the possibility that K740N and N745S WWP1 possess enhanced ubiquitin ligase activity and demonstrate that these variants are similar to the wild type (WT) in both autoubiquitination and PTEN ubiquitination. Furthermore, K740N and N745S WWP1 show dependencies similar to those of WT in terms of allosteric activation by an engineered ubiquitin variant, upstream E2 concentration, and substrate ubiquitin concentration. Transfected WWP1 WT and mutants demonstrate comparable effects on cellular PTEN levels. These findings challenge the idea that K740N and N745S WWP1 variants promote cancer by enhanced PTEN ubiquitination.
引用
收藏
页码:357 / 364
页数:8
相关论文
共 4 条
  • [1] The Ubiquitin Ligase Wwp1 Mediates Lysosomal Degradation of Connexin 43 through the Formation of K29-linked Polyubiquitin Chains.
    Abreha, M. H.
    Basheer, W. A.
    Matesic, L. E.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [2] Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination
    Zhao, Dingsheng
    Zhong, Guohui
    Li, Jianwei
    Pan, Junjie
    Zhao, Yinlong
    Song, Hailin
    Sun, Weijia
    Jin, Xiaoyan
    Li, Yuheng
    Du, Ruikai
    Nie, Jielin
    Liu, Tong
    Zheng, Junmeng
    Jia, Yixin
    Liu, Zifan
    Liu, Wei
    Yuan, Xinxin
    Liu, Zizhong
    Song, Jinping
    Kan, Guanghan
    Li, Youyou
    Liu, Caizhi
    Gao, Xingcheng
    Xing, Wenjuan
    Chang, Yan-Zhong
    Li, Yingxian
    Ling, Shukuan
    CIRCULATION, 2021, 144 (09) : 694 - 711
  • [3] S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression
    He, Weijing
    Zhang, Jingjing
    Liu, Baihui
    Liu, Xiangqi
    Liu, Gongbao
    Xie, Lulu
    He, Jiajun
    Wei, Meng
    Li, Kai
    Ma, Jing
    Dong, Rui
    Ma, Duan
    Dong, Kuiran
    Ye, Mujie
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 19 : 149 - 162
  • [4] Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyI)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyppyrrolidine-2-carboxamide (VH298)
    Soares, Pedro
    Gadd, Morgan S.
    Frost, Julianty
    Galdeano, Carles
    Ellis, Lucy
    Epemolu, Ola
    Rocha, Sonia
    Read, Kevin D.
    Ciulli, Alessio
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) : 599 - 618